Antihypertensive and antioxidant effects of hydroalcoholic extract from the aerial parts of Kelussia odoratissima Mozaff. in dexamethasone-induced hypertensive rats

Safaeian, Leila; Sajjadi, Seyed Ebrahim; Javanmard, Shaghayegh Haghjoo; Gholamzadeh, Hadi

Antihypertensive and antioxidant effects of hydroalcoholic extract from the aerial parts of Kelussia odoratissima Mozaff. in dexamethasone-induced hypertensive rats

Authors

¹ Department of Pharmacology and Toxicology, Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

² Department of Pharmacognosy, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

³ Department of Physiology, Applied Physiology Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Kelussia odoratissima Mozaff. is a monotypic endemic plant of Apiaceae growing wild in Iran. The aerial parts of this plant are used for treatment of hypertension, ulcer, and inflammatory conditions in folk medicine. In this study, the effects of hydroalcoholic extract of the aerial parts of K. odoratissima were evaluated in dexamethasone (Dex)-induced hypertension in male Wistar rats.
Materials and Methods: For induction of hypertension, Dex (30 μg/kg/day) was administered subcutaneously for 14 days. In a prevention study, rats received oral K. odoratissima extract (100, 200, and 400 mg/kg) from 4 days before Dex administration and during the test period (days 1-18). In a reversal study, K. odoratissima extract was administered orally from day 8 to 14. Systolic blood pressure (SBP) was evaluated using tail-cuff method. The hydrogen peroxide (H ₂ O ₂ ) concentration and ferric-reducing antioxidant power (FRAP) were measured in plasma samples.
Results: Administrations of Dex significantly induced an increase in SBP and in plasma H ₂ O ₂ and a decrease in body and thymus weights, and in FRAP value (P < 0.001). K. odoratissima extract dose-dependently prevented and reversed hypertension (P < 0.001). It also prevented and reduced the plasma H ₂ O ₂ concentration and prevented the body weight loss upon Dex administration at all doses (100-400 mg/kg, P < 0.001) but failed to improve FRAP value.
Conclusions: These results suggest antihypertensive and antioxidant effects of K. odoratissima extract in Dex-induced hypertension. Further studies are needed to elucidate the exact mechanism of the antihypertensive effect of this herbal medicine.

Keywords

References

1.	D′Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation 2008;117:743-53.
2.	Whitworth JA; World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;11:1983-92.
3.	Tabassum N, Ahmad F. Role of natural herbs in the treatment of hypertension. Pharmacogn Rev 2011;5:30-40.
4.	Christensen LP, Brandt K. Bioactive polyacetylenes in food plants of the Apiaceae family: Occurrence, bioactivity and analysis. J Pharm Biomed Anal 2006;41:683-93.
5.	Harborne JB. Flavonoid and phenylpropanoid patterns in the Umbelliferae. In: Heywood VH, editor. The Biology and Chemistry of the Umbelliferae. London: Academic Press; 1971. p. 1-8.
6.	Sajjadi SE, Zeinvand H, Shokoohinia Y. Isolation and identification of osthol from the fruits and essential oil composition of the leaves of Prangos asperula Boiss. Res Pharm Sci 2009;4:19-23.
7.	Mozaffarian V. Two new genera of Iranian umbelliferae. Bot Zhurn (Leningrad) 2003;88:88-94.
8.	Sajjadi SE, Shokoohinia Y, Moayedi NS. Isolation and identification of ferulic acid from aerial parts of Kelussia odoratissima Mozaff. Jundishapur J Nat Pharm Prod 2012;7:159-62.
9.	Ahmadi F, Kadivar M, Shahedi M. Antioxidant activity of Kelussia odoratissima Mozaff. in model and food systems. Food Chem 2007;105:57-64.
10.	Shahrani M, Rafieian M, Pilevarian AA, Shirzad H, Hashemzadeh M, Yousefi H, et al. The effect of Amirkabiria odoratissima M extract on gastric acid and pepsin secretion level in rat. J Shahrekord Univ Med Sci 2007;8:88-95.
11.	Pirbalouti AG, Malekpoor F, Enteshari SH, Yousefi M, Momtaz H, Hamedi B. Antibacterial activity of some folklore medicinal plants used by Bakhtiari Tribal in southwest Iran. Int J Biol 2010;2:55-63.
12.	Haj Hashemi VA, Ghannadi A, Soltani L. Analgesic and anti-inflammatory effects of Amirkabiria odoratissima. J Res Med Sci 2003;7:121-5.
13.	Rabbani M, Sajjadi SE, Sadeghi M. Chemical composition of the essential oil from Kelussia odoratissima Mozaff. and the evaluation of its sedative and anxiolytic effects in mice. Clinics (Sao Paulo) 2011;66:843-8.
14.	Asgary S, Naderi G, Dashti GH, Paknahad Z. Effect of Amirkabiria odorastissima Mozaffarian on the development and progression of fatty streaks in hypercholesterolemic rabbits. Phytother Res 2004;18:370-2.
15.	Asgari S, Naderi G, Jafarian-Dehkordi A, Askary N, Behagh AR. Fibrinolytic activity of Amirkabiria odoratissima Mozaffarian. J Med Plants 2005;13:50-9.
16.	Yoo KM, Lee CH, Lee H, Moon B, Lee CY. Relative antioxidant and cytoprotective activities of common herbs. Food Chem 2008;106:929-36.
17.	Zhang Y, Wu JH, Vickers JJ, Ong SL, Temple SE, Mori TA, et al. The role of 20-hydroxyeicosatetraenoic acid in adrenocorticotrophic hormone and dexamethasone-induced hypertension. J Hypertens 2009;27:1609-16.
18.	Ong SL, Vickers JJ, Zhang Y, McKenzie KU, Walsh CE, Whitworth JA. Role of xanthine oxidase in dexamethasone-induced hypertension in rats. Clin Exp Pharmacol Physiol 2007;34:517-9.
19.	Wolff SP. Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Methods Enzymol 1994;233C: 182-9.
20.	Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": The FRAP assay. Anal Biochem 1996;239:70-6.
21.	Ong SL, Zhang Y, Whitworth JA. Mechanisms of dexamethasone-induced hypertension. Curr Hypertens Rev 2009;5:61-74.
22.	Safaeian L, Zabolian H. Antioxidant effects of bovine lactoferrin on dexamethasone-induced hypertension in rat. ISRN Pharmacol 2014;2014:943523.
23.	Zhang Y, Croft KD, Mori TA, Schyvens CG, McKenzie KU, Whitworth JA. The antioxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the rat. Am J Hypertens 2004;17:260-5.
24.	Bachhav SS, Pati SD, Bhutada MS, Surana SJ. Oleanolic acid prevents glucocorticoid-induced hypertension in rats. J Phytother Res 2011;10:1435-9.
25.	Safaeian L, Zabolian H. Antihypertensive effect of lactoferrin on dexamethasone-induced hypertension in rat. J Isfahan Med Sch 2013;31:1096-104.
26.	Beck JJ, Chou SC. The structural diversity of phthalides from the Apiaceae. J Nat Prod 2007;70:891-900.
27.	Yu Y, Du JR, Wang CY, Qian ZM. Protection against hydrogen peroxide-induced injury by Z-ligustilide in PC12 cells. Exp Brain Res 2008;184:307-12.
28.	Yan S, Qiao GF. Effect of the oil of Angelica sinensis on contractial function of isolated uterine smooth muscle of mice. Chin Tradit Herb Drugs 2000;31:604-6.
29.	Cao YX, Zhang W, He JY, He LC, Xu CB. Ligustilide induces vasodilatation via inhibiting voltage dependent calcium channel and receptor-mediated Ca2+ influx and release. Vascul Pharmacol 2006;45:171-6.
30.	Liang MJ, He LC, Yang GD. Screening, analysis and in vitro vasodilation of effective components from Ligusticum chuanxiong. Life Sci 2005;78:128-33.
31.	Tsi D, Tan BK. Cardiovascular pharmacology of 3-n -butylphthalide in spontaneously hypertensive rats. Phyhother Res 1997;11:576-82.
32.	Perez-Vizcaino F, Duarte J. Flavonols and cardiovascular disease. Mol Aspects Med 2010;31:478-94.
33.	Li PG, Xu JW, Ikeda K, Kobayakawa A, Kayano Y, Mitani T, et al. Caffeic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II in stroke-prone spontaneously hypertensive rats. Hypertens Res 2005;28:369-77.
34.	Suzuki A, Yamamoto M, Jokura H, Fujii A, Tokimitsu I, Hase T, et al. Ferulic acid restores endothelium-dependent vasodilation in aortas of spontaneously hypertensive rats. Am J Hypertens 2007;20:508-13.
35.	Alam MA, Sernia C, Brown L. Ferulic acid improves cardiovascular and kidney structure and function in hypertensive rats. J Cardiovasc Pharmacol 2013;61:240-9.
36.	Feng W, Min L, Lianchun Y, Jingyuan W, Min L, Fei L. A new kind of non-peptide endothelin antagonist Caffeic acid ferulic acid. Yaoxue Xuebao 1999;34:898-901.
37.	Hasani-Ranjbar S, Larijani B, Abdollahi M. A systematic review of the potential herbal sources of future drugs effective in oxidant-related diseases. Inflamm Allergy Drug Targets 2009;8:2-10.
38.	Bartosz M, Kedziora J, Bartosz G. Antioxidant and prooxidant properties of captopril and enalapril. Free Radic Biol Med 1997;23:729-35.
39.	de Cavanagh EM, Fraga CG, Ferder L, Inserra F. Enalapril and captopril enhance antioxidant defenses in mouse tissues. Am J Physiol 1997;272:R514-8.

Advanced Biomedical Research